BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16221398)

  • 1. [Valproate-caused encephalopathy].
    Thygesen KS; Wolf P
    Ugeskr Laeger; 2005 Oct; 167(40):3793-4. PubMed ID: 16221398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Valproate can induce reversible encephalopathy].
    Prakash S; Harbo T; Christensen J
    Ugeskr Laeger; 2014 Nov; 176(45):. PubMed ID: 25394838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Valproate can induce reversible encephalopathy].
    Prakash S; Harbo T; Christensen J
    Ugeskr Laeger; 2015 May; 177(20):945-6. PubMed ID: 26535436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is valproate encephalopathy under-recognised in older people? A case series.
    Beyenburg S; Back C; Diederich N; Lewis M; Reuber M
    Age Ageing; 2007 May; 36(3):344-6. PubMed ID: 17374600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Encephalopathies caused by valproate].
    Göbel R; Görtzen A; Bräunig P
    Fortschr Neurol Psychiatr; 1999 Jan; 67(1):7-11. PubMed ID: 10065384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate-induced encephalopathy.
    Rehman A; Zafar S
    J Coll Physicians Surg Pak; 2005 Sep; 15(9):571-2. PubMed ID: 16181582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A valproate-induced encephalopathy without hyperammonemia].
    Parize P; Beuret P; Fischer C
    Ann Fr Anesth Reanim; 2007 Dec; 26(12):1084-5. PubMed ID: 18029137
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.
    Chopra A; Kolla BP; Mansukhani MP; Netzel P; Frye MA
    Gen Hosp Psychiatry; 2012; 34(3):290-8. PubMed ID: 22305367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case report of valproate encephalopathy].
    Miyamoto T; Miyamoto M; Hirata K; Katayama S
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S; Radhakrishnan K
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid induced encephalopathy--19 new cases in Germany from 1994 to 2003--a side effect associated to VPA-therapy not only in young children.
    Gerstner T; Buesing D; Longin E; Bendl C; Wenzel D; Scheid B; Goetze G; Macke A; Lippert G; Klostermann W; Mayer G; Augspach-Hofmann R; Fitzek S; Haensch CA; Reuland M; Koenig SA
    Seizure; 2006 Sep; 15(6):443-8. PubMed ID: 16787750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Valproate-induced hyperammonemic encephalopathy in a patient with Sjögren's syndrome].
    Nakazato Y; Ando S; Yamamoto T; Tamura N; Shimazu K
    Rinsho Shinkeigaku; 2004 Oct; 44(10):682-5. PubMed ID: 15568484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate-induced hyperammonemic encephalopathy treated by hemodialysis.
    Tsai MF; Chen CY
    Ren Fail; 2008; 30(8):822-4. PubMed ID: 18791959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting.
    Dealberto MJ
    Int Clin Psychopharmacol; 2007 Nov; 22(6):330-7. PubMed ID: 17917551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of hyperammonaemic encephalopathy due to valproic acid.
    Prins MC; van Meijel JJ
    Neth J Med; 2011 Sep; 69(9):389-91. PubMed ID: 21978982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate Induced Hyperammonemic Encephalopathy.
    Qayyum W; Yousafzai ZA; Iqbal MS; Khan S; Amin QK; Shafiqs I
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S1038-S1039. PubMed ID: 36550671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A; Lauria G; Grimod G; Bianchi G; Salmaggi A
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproate-Associated Hyperammonaemic Encephalopathy.
    Anthonipillai P; Sharp G; Kimber J; Ziauddin V
    Acute Med; 2022; 21(1):43-46. PubMed ID: 35342909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.